ArticleBMC microbiology2026
Metabolomic profiling of Bacillus amyloliquefaciens MU-10 and its antagonistic effects on Cercospora arachidicola.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biocontrol of phytopathogenic fungi byAIMS microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundEarly leaf spot disease in peanut severely impacts crop yield and quality. In response, biological control by Bacillus strains offers an alternative approach to replace harmful chemical fungicides, as these bacteria produce bioactive secondary metabolites. The effectiveness of these metabolites greatly relies on the submerged fermentation process, which in turn depends on optimizing the nutrient media-especially since there is a significant difference between nutrient-optimized fermentation medium (OP) and nonoptimized fermentation medium (NOP).
resultsIn the present study, we isolated an antagonistic strain, Bacillus amyloliquefaciens MU-10, from soil and identified it. According to in vitro experiments, strain MU-10 exhibited potent antifungal activity against C. arachidicola, with an inhibition zone of 76 mm. Similarly, under greenhouse conditions, the disease control efficiency of the MU-10 strain against peanut leaf spot disease was 93.33%. SEM analysis revealed that the hyphae of the pathogen were destroyed and that the effect of MU-10 reduced the abundance of spores. UHPLC-MS/MS was used to elucidate the bioactive secondary metabolites produced by strain MU-10 in OP and NOP submerged fermentation. A total of 831 metabolites were detected in OP, 32% of which were classified as organic acids. Among these were 83 differentially expressed metabolites (DEMs). According to the VIP scores, 12 metabolites were identified as key contributors to group separation, including the upregulated 3-O-acetylisopimaric acid and vanillylamine. Conversely, pyrrole-2-carboxylic acid was identified as a downregulated VIP metabolite in OP. The receiver operating characteristic (ROC) curves confirmed all the metabolic results. Pure compound validation was confirmed by the use of commercially synthesized vanillylamine, pyrrole-2-carboxylic acid, and syringic acid as key antifungal agents.
conclusionNutrient-optimized fermentation significantly increased the production of Bacillus-based biocontrol products. This improvement represents a significant advancement in sustainable, environmentally friendly crop disease management, providing an effective solution for controlling early leaf spot in peanuts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.